Church, D., Kip, K., Stapleton, P. ยท Journal of Nervous and Mental Disease ยท 2022
Following correction of standard-deviation errors in the original meta-analysis, an independent statistician's reanalysis of 6 identified component studies (3 meeting Division 12 Task Force quality criteria) found slightly greater effects than the original analysis, reaffirming that the acupoint-tapping component of EFT is an active ingredient rather than an inert placebo.
If findings like these hold up in larger trials, the promise is simple: a low-cost, self-administered tool that could reach people who can't easily access traditional care โ at home, between appointments, or where there aren't enough clinicians to go around.
The natural next step: longer-term follow-up to see how durable the benefit is, and an active ('sham tapping') control to isolate what's doing the work.
| Design | Dismantling study |
|---|---|
| Participants | 6 studies pooled |
| Population | Component (dismantling) studies isolating the acupoint-tapping ingredient of EFT |
| Comparison group | sham acupoints or alternative components (dismantling design) |
| Journal | Journal of Nervous and Mental Disease |
| Year | 2022 |
| Country | United States |
| Language | English |
| Method | EFT / tapping |
| Publication type | Study / trial |
| Verification | โ Confirmed against the primary source |
Church, D., Kip, K., & Stapleton, P. (2022). Corrigendum supports therapeutic contribution of acupoint tapping to EFT's observed effects. Journal of Nervous and Mental Disease. https://doi.org/10.1097/NMD.0000000000001439
This record is part of the Tapping Evidence Base โ an openly-sourced, fully-referenced directory of the research on EFT/tapping. Explore more studies on How It Works (Biology)
A ready-made graphic โ right-click or long-press to save the image.